For 2025, Gentex forecasts $2.4 billion to $2.45 billion in revenue, which would be up from $2.31 billion last year. Analysts polled by FactSet had been projecting $2.58 billion. Write to Dean Seal at ...

The S&P 500's technology sector just ended its worst week since early September, after Chinese artificial-intelligence company DeepSeek seemed to startle investors' perception of winners and losers in ...

Shares of Brookfield Renewable Partners rose after the company logged a narrower-than-expected loss in the fourth quarter and said that it sees a strong demand for clean power in 2025. Shares traded 3 ...

The Federal Reserve’s preferred inflation gauge moved even higher in December, driven in part by rising food and energy prices. However, a closely watched measurement of underlying inflation trends ...

AbbVie Inc.’s stock rose 7.7% Friday to lead S&P 500 gainers after the drug company beat fourth-quarter earnings estimates ...

Colgate-Palmolive's (CL) fourth-quarter earnings came in ahead of Wall Street's estimates, while revenue posted a surprise decline amid weakness in North America and Latin America. Per-share adjusted ...

Goldman Sachs analyst Bonnie Herzog maintains a Buy rating on Colgate-Palmolive, with a price target of $106. Despite Q4 EPS of $0.91 exceeding expectations, organic sales growth of 4.3% fell short.

Eurozone growth slowed to a halt in the fourth quarter last year, dragged by contractions in major powers Germany and France ...

Tesla (NASDAQ: TSLA) rallied 1% on Friday, rebounding from its 50-day moving average after a mixed earnings report. The ...

January 2025 saw strong gains in US and international equities, led by Health Care sector performance and concerns about inflation. Click for my monthly recap.

Broadridge Financial Solutions delivered impressive second-quarter results, beating both revenue and earnings expectations.